5-fluorouracil plus leucovorin in women with metastatic breast cancer : a phase II study

Because leucovorin increases the antitumor activity of 5-fluorouracil (5-FU) in multiple tumor model systems, we performed a clinical trial to evaluate this combination in women who had received one or no prior chemotherapy regimens for metastatic breast cancer. Thirty-six women with measurable meta...

Ausführliche Beschreibung